Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
62
datasets available to search
ShareScore release 0.9.0
Dataset results
62 results for “CYP”
Fig. 1 in L-DOPA synthesis in Mucuna pruriens (L.) DC. is regulated by polyphenol oxidase and not CYP 450/tyrosine hydroxylase: An analysis of metabolic pathway using biochemical and molecular markers
Fig. 1. The proposed hypothetical pathway for catecholamine biosynthesis in Mucuna pruriens.
Connecting Breath and Mind for CYP With Long COVID
ClinicalTrials.gov study NCT05705154. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Vamorolone CYP3A4 Induction on Midazolam (a Sensitive CYP 3A4 Substrate) Pharmacokinetics
ClinicalTrials.gov study NCT06689527. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
ClinicalTrials.gov study NCT00786422. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Voxelotor CYP and Transporter Cocktail Interaction Study
ClinicalTrials.gov study NCT05981365. IPD Sharing: NO. Countries: 1. Publications: 0.
Transcriptome profiling of bladders of CYP-treated C57BL6/J mice (male and female)
GEO Series GSE221783. Mus musculus. 12 samples. Type: Expression profiling by high throughput sequencing.
The expression profile of cytochromes P450 (CYPs) and aldo-keto reductases (AKRs) in post-treatment breast carcinomas
GEO Series GSE56259. Homo sapiens. 111 samples. Type: Expression profiling by RT-PCR.
Sequencing of commercially-available pancreatic cancer cell lines reveals selective CYP3A5 overexpression among xenobiotic-metabolizing CYPs.
GEO Series GSE138437. Homo sapiens. 27 samples. Type: Expression profiling by high throughput sequencing.
Cytochrome P450 2D6 (CYP 450 2D6) Genotype and Flecainide Efficacy
ClinicalTrials.gov study NCT00945867. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
ClinicalTrials.gov study NCT00247702. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants
ClinicalTrials.gov study NCT07223671. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibitor (Itraconazole) and Inducer (Rifampin) on the Drug Levels of Golcadomide (BMS-986369) in Healthy Participants
ClinicalTrials.gov study NCT06363630. IPD Sharing: YES. Countries: 1. Publications: 0.
CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients
ClinicalTrials.gov study NCT02100761. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ARQ 197 in Healthy Volunteers to Assess the Pharmacokinetic (PK) Profile in Extensive and Poor Metabolizers as Defined by Cytochrome P450 2C19 (CYP 2C19) Genotype
ClinicalTrials.gov study NCT00651638. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy
ClinicalTrials.gov study NCT02381080. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Assess the Influence of Cenobamate on the PK of Cytochrome P450 (CYP) Probe Drugs As a Means of Predicting Drug-drug Interactions
ClinicalTrials.gov study NCT03234699. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 Substrates
ClinicalTrials.gov study NCT02211079. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Effects of Cytochrome P450 (CYP) 3A4 Inducer Carbamazepine on Tavapadon Pharmacokinetics in Healthy Adult Participants
ClinicalTrials.gov study NCT05581823. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects
ClinicalTrials.gov study NCT01873339. IPD Sharing: YES. Countries: 1. Publications: 0.
KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism
ClinicalTrials.gov study NCT06566794. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.